Epidemiology of encapsulating peritoneal sclerosis in Japan

Peritoneal Dialysis International

Volumn 25, Issue SUPPL. 4, 2005, Pages

  Kawanishi, Hideki ^a   Moriishi, Misaki ^a  

^a TSUCHIYA GENERAL HOSPITAL   (Japan)

Author keywords

Encapsulating peritoneal sclerosis; Epidemiology; EPS

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORHEXIDINE; CORTICOSTEROID DERIVATIVE; FIBRIN; INTERLEUKIN 6; METOPROLOL; PERITONEAL DIALYSIS FLUID; PLASTICIZER; PRACTOLOL; TIMOLOL;

ARTICLE; DATA ANALYSIS; FATALITY; HEALTH SURVEY; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; JAPAN; LONG TERM CARE; LUNG FIBROSIS; MORTALITY; PATIENT MONITORING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; RISK ASSESSMENT; SCLEROSING PERITONITIS; STANDARDIZATION; TOTAL PARENTERAL NUTRITION; TREATMENT WITHDRAWAL;

EID: 27744609267     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502504s03     Document Type: Article

References (27)

1. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S43-55.
2. Rottembourg J, Issad B, Langlois P, Tranbaloc R, Adamou A, DeGroc F, et al. Loss of ultrafiltration and sclerosing encapsulating peritonitis during CAPD: evaluation of the potential risk factors. Adv CAPD 1985; 1:109-17.
3. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28:420-7.
4. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13:154-9.
5. Oules R, Challah S, Brunner FP. Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant 1988; 3:66-9.
6. Bentley PG, Higgs DR. Peritoneal tuberculosis with ureteric obstruction, mimicking retroperitoneal fibrosis. Br J Urol 1976; 48:170.
7. Sugarbaker PH, Landy D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 1990; 65:1495-501.
8. Markman M, Cleary S, Howell SB, Lucas WE. Complications of extensive adhesion formation after intraperitoneal chemotherapy. Surg Gynecol Obstet 1986; 162:445-8.
9. Mackow RC, Winchester JF, Argy WP, Andrews PM, Fields PA, Bates S, et al. Sclerosing encapsulating peritonitis in rats: an experimental study with intraperitoneal antiseptics. Contrib Nephrol 1987; 57:213-18.
10. Lo WK, Chan KT, Leung AC, Pang SW, Tse CY. Sclerosing peritonitis complicating continuous ambulatory peritoneal dialysis with the use of chlorhexidine in alcohol. Adv Perit Dial 1990; 6:79-84.
11. Brown F, Baddeley H, Read AE, Davies JD, McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet 1974; 2:1477-81.
12. Thompson RP, Jackson BT. Sclerosing peritonitis due to practolol. Br Med J 1977; 1:1393-4.
13. Eltringham WK, Espiner HJ, Windsor CW, Griffiths DA, Davies JD, Baddeley H, et al. Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management. Br J Surg 1977; 64:229-35.
14. Hall DR, Morrison JB, Edwards FR. Pleural fibrosis after practolol therapy. Thorax 1978; 33:822-4.
15. Dobbie JW, Lloyd JK. Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant. Perit Dial Int 1989; 9:215-19.
16. Baxter-Smith DC, Monypenny IJ, Dorricott NJ. Sclerosing peritonitis in patient on timolol (Letter). Lancet 1978; 2:149.
17. Clark CV, Terris R. Sclerosing peritonitis associated with metoprolol (Letter). Lancet 1983; 1:937.
18. Nakamoto H, Kawaguchi Y, Suzuki H. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan. Adv Perit Dial 2002; 18:119-23.
19. McLaughlin K, Butt G, Madi A, McMillan M, Mactier R. Sclerosing peritonitis occurring in a hemodialysis patient. Am J Kidney Dis 1996; 27:729-32.
20. Yanagi H, Kusunoki M, Yamamura T. Possible development of idiopathic sclerosing encapsulating peritonitis. Hepatogastroenterology 1999; 46:353-6.
21. Frigerio L, Taccagni GL, Mariani A, Mangili G, Ferrari A. Idiopathic sclerosing peritonitis associated with florid mesothelial hyperplasia, ovarian fibromatosis, and endometriosis: a new disorder of abdominal mass. Am J Obstet Gynecol 1997; 176:721-2.
22. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Encapsulating peritoneal sclerosis-like findings in a hemodialysis patient without a history of peritoneal dialysis. Adv Perit Dial 2003; 19:176-9.
23. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablockow VR, Iwatsuki S, et al. Sclerotic thickening of the penitoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140:1201-3.
24. Denis J, Paineau J, Potel G, Fontenaille C, Guenel J. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1980; 93:508.
25. Slingeneyer A. Preliminary reporton a cooperative international study on sclerosing encapsulating peritonitis. Contrib Nephrol 1987; 57:239-47.
26. Kawanishi H, Kawaguchi Y. Prevalence and therapeutic outcome of sclerosing encapsulating peritonitis (EPS) - a multicenter study in Japan (Japanese). Jin To Toseki 2000; 49(Suppl):225-8.
27. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004; 44:729-37.